FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094136 [Registered on: 02/09/2025] Trial Registered Prospectively
Last Modified On: 02/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study of the effect of Bilvadi Churna (Granules) in comparision to Kutaj Ghanvati in Atisara in children  
Scientific Title of Study   Comparative clinical evaluation of Bilvadi Churna (Granules) and Kutaj Ghanvati in Atisara in children 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Akash Ramesh Burud 
Designation  PG Scholar 
Affiliation  Gurukul Campus Uttarakhand Ayurved University, Haridwar  
Address  OPD 9 Department of Kaumarbhritya Gurukul Campus Uttarakhand Ayurved University Haridwar Uttarakhand

Hardwar
UTTARANCHAL
249404
India 
Phone  7030710396  
Fax    
Email  akashburud12@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr GP Garg 
Designation  Professor and HOD Department of Kaumarbhritya 
Affiliation  Gurukul Campus Uttarakhand Ayurved University, Haridwar  
Address  OPD 9 Department of Kaumarbhritya Gurukul Campus Uttarakhand Ayurved University Haridwar Uttarakhand

Hardwar
UTTARANCHAL
249404
India 
Phone  6395611281  
Fax    
Email  drgarggp@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr GP Garg 
Designation  Professor and HOD Department of Kaumarbhritya 
Affiliation  Gurukul Campus Uttarakhand Ayurved University, Haridwar  
Address  OPD 9 Department of Kaumarbhritya Gurukul Campus Uttarakhand Ayurved University Haridwar Uttarakhand

Hardwar
UTTARANCHAL
249404
India 
Phone  6395611281  
Fax    
Email  drgarggp@gmail.com  
 
Source of Monetary or Material Support  
Uttarakhand Ayurveda University Gurukul Campus Haridwar Uttarakhand India Pin code 249404 
 
Primary Sponsor  
Name  Akash Ramesh Burud 
Address  OPD No 9 Department of Kaumarbhritya Uttarakhand Ayurved University Gurukul Campus Haridwar 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Akash Ramesh Burud  Uttarakhand Ayurved University Gurukul Campus Haridwar  OPD 9 PG Department of Kaumarbhritya Gurukul Campus Uttarakhand Ayurved University Haridwar Uttarakhand
Hardwar
UTTARANCHAL 
7030710396

akashburud12@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Gurukul Campus  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K928||Other specified diseases of the digestive system. Ayurveda Condition: ATISARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Kutaj Ghanvati, Reference: Siddha Yoga Sangraha, Author - Vaidya Yadavji Trikamaji Acharya, Chapter 2 - Atisara Pravahika Grahnyadhikara, Page No. 26, Kutaj - Bhavaprakash, Guduchyadi varga, Shloka No. 118, Ativisha- Bhavaprakash, Haritkyadi varga, Shloka No. 214, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 125(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Boiled water at room temperature), Additional Information: 5-10 years - 125mg TDS 10-16 years- 250mg TDS
2Intervention ArmDrugClassical(1) Medicine Name: Bilvadi Churna (Granules), Reference: Chakradath Samhita, Vyakhyakar Dr Indradev Tripathi, Chapter No. 64 Balroga Chikitsa, Shloka No. 31, Page No. 396, Route: Oral, Dosage Form: Khanda /Granules, Dose: 5(g), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Boiled water at room temperature), Additional Information: 5-10 years- 5gm TDS 10-16 years- 10gm TDS
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  16.00 Year(s)
Gender  Both 
Details  1. Case of Atisara as per classical symptoms: Muhura Muhura Mala Pravritti (Increased
Frequency of stool),Udara Shoola (Abdominal pain), Atidrava Mala Pravritti (Loose
Consistency of stool), Agnimandya (Decreased appetite), Durgandhit Mala (Foul smell)
2. Patient suffering from Acute diarrhoea (with history upto 7 days) 
 
ExclusionCriteria 
Details  1. Children below age of 5 years and above 16 years.
2. Severe diarrhoea.
3. Persistent vomiting.
4. Bloody stools.
5. Moderate and severe dehydration.
6. Known case of worm infestation induced diarrhoea.
7. Patient suffering from any other Systemic disorder, Congenital anomalies,
Immune deficiency disorder and Inborn errors of metabolism. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Muhura Muhura Mala Pravritti (Increased
Frequency of stool)
Udara Shoola (Abdominal pain)
Atidrava Mala Pravritti (Loose
Consistency of stool)
Agnimandya (Decreased appetite)
Durgandhit Mala (Foul smell) 
The assessment of patient will be done at 1st day, 4th day and 7th day and follow-up (post treatment) will done after 3rd day of the cessation of medicine.  
 
Secondary Outcome  
Outcome  TimePoints 
Complete cure from all classical symptoms of Atisara  The assessment of patient will be done at 1st day, 4th day and 7th day and follow-up (post treatment) will done after 3rd day of the cessation of medicine.  
 
Target Sample Size   Total Sample Size="34"
Sample Size from India="34" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a Comparative clinical evaluation of Bilvadi Churna (Granules) and Kutaj Ghanvati in Atisara in children for the age group of 5 to 16 years for 7 days. Study will be conducted at UAU, Gurukul Campus, Haridwar on 34 patients. Assessment will be done on the basis of subjective and objective parameters. Study will be conducted at OPD/IPD level of PG department of Kaumarbhritya. The Assessment will be done at 1st day, 4th day and 7th day and follow-up (post treatment) will be done after the 3rd day of the cessation of medicine (10th day) and result obtained will be tabulated and statistically analyzed using appropriate tests. 
Close